Picture of AbClon logo

174900 AbClon Share Price

0.000.00%
kr flag iconLast Trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative strength (%)
1m-14.48%
3m
6m
1yr
Volume change (%)
10d/3m
Price vs... (%)
52w High-60.55%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total RevenueKR₩m3,120.333,532.433,920.7914,375.032,771.185,000n/a7.3%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for 174900

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecast

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of AbClon EPS forecast chart

Profile Summary

AbClon Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of antibody drug. The Company developed a bio synergy antibody, a therapeutic antibody for a new mechanism that is different from conventional therapeutic agents, and is based on the YPLUS and AffiMab platforms. The company's products include AC101, AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103. The Company distributes its products within domestic market and to overseas markets.

Directors

    Last Annual
    December 31st, 2020
    Last Interim
    March 31st, 2021
    Incorporated
    June 25th, 2010
    Public Since
    September 18th, 2017
    No. of Shareholders
    27,799
    No. of Employees
    53
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    15,278,069
    Blurred out image of a map
    Address
    SEOUL, 08381
    Web
    http://www.abclon.co.kr/
    Phone
    +82 221091294
    Auditors
    Ernst & Young Han Young

    174900 Share Price Performance

    Upcoming events for 174900

    Similar to 174900

    Picture of ALTEOGEN ORD logo

    ALTEOGEN ORD

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ANTEROGEN ORD logo

    ANTEROGEN ORD

    kr flag iconKorea Exchange - KOSDAQ

    Picture of BIO SOLUTION ORD logo

    BIO SOLUTION ORD

    kr flag iconKorea Exchange - KOSDAQ

    BNC ORD

    kr flag iconKorea Exchange - KOSDAQ

    Picture of CELLTRION HEALTH ORD logo

    CELLTRION HEALTH ORD

    kr flag iconKorea Exchange - KOSDAQ

    FAQ